Detailed chapter

Breast Screening and Follow-up

Turkey’s 40–69 biennial mammography programme, high-risk MRI pathways, pregnancy/breastfeeding imaging rules, and post-cancer surveillance — compressed into a practical map.

Breast care runs on two tracks: evaluation of symptoms, and asymptomatic periodic screening. Screening aims to find lesions before they are felt. Turkey’s Ministry of Health population programme recommends mammography every two years for average-risk women aged 40–69 (for example via KETEM centres). High-risk people follow a different calendar — often earlier start and denser imaging that may include MRI. Exact schedules are personalised with your clinician.

Breast screening and follow-up — educational figure — Breast screening and follow-up · educational illustration · English labels below

Figure labels (English)

Awareness
Clinical exam
Imaging

Related educational figures

Tap a figure to enlarge.

Mammography, US, MRI
After treatment: surveillance

Who may be a candidate?

Average-risk women planning age-appropriate mammography in Turkey
High-risk individuals needing earlier, denser protocols including MRI
Pregnant or breastfeeding patients with new breast symptoms
Survivors needing post-treatment imaging and clinical follow-up

Possible advantages

National 40–69 biennial mammography gives a clear average-risk backbone
High-risk MRI pathways catch disease earlier in genetically elevated risk
Pregnancy/breastfeeding rules prioritise ultrasound so diagnosis is not deferred to delivery

Limits & realistic expectations

Dense breasts may need ultrasound added to mammography
Average-risk calendars must not be applied unchanged to high-risk genetics
Self-awareness never replaces scheduled mammography

Step-by-step overview

1
Know your risk lane
Average-risk population screening differs from genetic/family high-risk protocols — confirm which lane you are in.
2
Keep the three pillars
Breast awareness, clinical examination, and age-appropriate imaging work together; none fully replaces the others.
3
Match the modality
Screening mammography (± ultrasound if dense); ultrasound first for young, pregnant, or symptomatic patients; MRI for selected high-risk or problem-solving cases.
4
Act on new findings
New lumps, skin or nipple change, bloody discharge, or axillary swelling skip the waiting list for the next screen — seek earlier review.

Key points

Three pillars of control
Tap for details
Breast awareness (knowing your normal), clinical breast examination, and age-appropriate imaging (mammography ± ultrasound ± MRI) work together. None replaces the others; awareness never cancels a scheduled mammogram.
- Awareness: notice change early
- Clinical exam: clinician assessment
- Imaging: mammography / ultrasound / MRI
Average risk before 40, and ages 40–69 in Turkey
Tap for details · key note inside
Before 40, routine mammography is usually not advised for average risk; symptoms lead with exam and ultrasound. From 40–69, Turkey’s Ministry of Health programme recommends mammography every two years. Dense tissue may add ultrasound; high-risk people use a separate, denser calendar.
- Turkey (Ministry of Health): ages 40–69
- Frequency: mammography every two years
- Dense breasts: consider added ultrasound
- High risk: separate, more intensive protocol
Later life and high-risk intensification
Tap for details · key note inside
Benefit–harm balance is clearest in mid-life; continuing after 70 depends on health and life expectancy. High-risk pathways often start around ages 25–30 (or 10 years before the earliest family diagnosis) with annual mammography plus annual MRI when indicated — genetics counselling may accompany this.
- Genetic or strong family history
- Prior chest radiotherapy
- Atypia / LCIS history
- Often: annual mammography + MRI
Choosing mammography, ultrasound, or MRI
Tap for details
Mammography is the screening backbone from 40 upward and excels at calcifications and architectural distortion. Ultrasound has no radiation — first-line for young, dense, pregnant, or symptomatic breasts and for cyst-versus-solid sorting. MRI serves high-risk screening, unresolved problem cases, and selected staging — not routine population screening.
Pregnancy and breastfeeding
Tap for details · key note inside
Concerning breast symptoms in pregnancy are not deferred to delivery: exam, then ultrasound first; shielded mammography only if needed; contrast MRI generally avoided; biopsy when indicated is not delayed. During lactation the path is similar — empty the breast before imaging; non-resolving redness or mass needs imaging ± biopsy rather than prolonged ‘mastitis only’ assumptions.
- 1. Clinical examination
- 2. Ultrasound first
- 3. Shielded mammography if still needed
- 4. Contrast MRI: usually avoided / special decision
- 5. Biopsy not deferred when suspicion persists
After benign findings and after cancer treatment
Tap for details
Simple cysts often return to the routine screen. Typical fibroadenomas may have 6–12 month ultrasound checks. BI-RADS 3 lesions classically use short-interval follow-up (for example 6 months). After cancer treatment, early-year clinic visits are denser; conserved breasts usually have annual mammography and the other breast continues screening; mastectomy sides rely on exam ± selective ultrasound/MRI, plus systemic aftercare.
- BI-RADS 3: short-interval imaging (e.g. 6 months)
- Simple cyst: often back to routine screening
- Post-cancer: closer clinical visits early, then spaced
Do not wait for the next screen if…
Tap for details · key note inside
A new palpable lump, skin or nipple change, bloody or unilateral discharge, axillary swelling, or peau d’orange/redness is a reason for early clinical assessment — not a reason to wait for the next screening appointment.
Important
Tap for details · key note inside
Educational information only — not a substitute for clinical evaluation or personalised advice. Screening age and frequency are individual; national programmes set a backbone, and high-risk or post-cancer plans differ. Seek care promptly for new lumps, discharge, or skin change.

Frequently asked questions

What is Turkey’s average-risk mammography schedule?
Tap for details
The Ministry of Health programme recommends mammography every two years for average-risk women aged 40–69. Dense breasts may add ultrasound; some individual plans discuss annual mammography.
Who needs MRI screening?
Tap for details
High-risk people — for example pathogenic BRCA1/2 or other high-penetrance mutations, strong family history, prior chest radiotherapy at a young age, or markedly elevated lifetime risk — often follow annual mammography plus annual breast MRI.
How is imaging sequenced in pregnancy?
Tap for details
Do not defer concerning symptoms until delivery. Clinical exam then ultrasound first (no ionising radiation). Shielded mammography only if suspicion remains; contrast MRI is generally avoided. Biopsy is not postponed when indicated.
What about breastfeeding?
Tap for details
Exam plus ultrasound first; emptying the breast before imaging improves quality. Mammography when needed is allowed. Non-resolving redness or mass must not be dismissed as mastitis alone.
How does follow-up change after breast cancer treatment?
Tap for details
Clinical visits are closer in early years. Conserved breasts usually have annual mammography; the contralateral breast continues screening. After mastectomy, routine mammography of that side is not used — exam ± ultrasound/MRI as indicated.

More chapters in this hub

Appointment / info

+90 542 725 50 70 WhatsApp Tumor board Back to hub →Full Turkish chapter →

Educational information only; not a substitute for clinical evaluation.

Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.